AMRAD

Welcome to the Brand page for “AMRAD”, which is offered here for In the statement, column 2, line 12, after namely, conducting clinical trials; biotechnology should be inserted.;medical and clinical medical reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of dna, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro; pharmaceutical preparation for human and veterinary use in the treatment of blood disorders, viral disease and nervous system dysfunction, cancer, bone disease, liver disease, cardiac disorders, infertility, pregnancy disorders, and inflammation; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology;chemical preparations for scientific and research use, proteinaceous reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of dna; reagents for scientific or medical research use, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro and for the expression, isolation and detection of recombination; biochemicals, monoclonal antibodies for in vitro scientific or research use in detecting auto immune disease, microbial disease, protein levels, genetic abnormalities, and pathogens;medical testing; pharmaceutical advice;product research and development in the field of drug discovery; research and development for new products for others in the field of drug discovery; medical and scientific research, * conducting clinical trials; biotechnology * consultation and research; pharmaceutical drug development services;.

Its status is currently believed to be active. Its class is unavailable. “AMRAD” is believed to be currently owned by “AMRAD CORPORATION LIMITED”.